HRT Financial LP Increases Stake in Aditxt, Inc.
HRT Financial LP buys over 4.25 million shares of Aditxt, Inc.
Key Points
- HRT Financial LP purchased 4,252,767 shares of Aditxt, Inc. at an average price of $0.02 per share, totaling $85,055.34.
- Aditxt, Inc. trades on NasdaqCM under the ticker ADTX with a market cap of $10,607 and a 52-week range from $0.01 to $53,453.52.
- Peers include Geode Capital Management and Morgan Stanley, which hold 434 and 296 shares respectively.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
HRT Financial LP recently increased its investment in Aditxt, Inc. (NasdaqCM: ADTX) by purchasing 4,252,767 shares at an average price of $0.02 each. This transaction, dated June 12, 2026, is valued at approximately $85,055.34.
What Changed in HRT Financial LP's Aditxt Position
HRT Financial LP's recent transaction reflects a significant increase in its stake in Aditxt, Inc. The firm bought 4,252,767 shares, marking a substantial addition to its holdings in the biotechnology company.
Other Institutional Activity in Aditxt
Other institutional investors also have positions in Aditxt. Geode Capital Management, LLC holds 434 shares valued at about $11,472. Morgan Stanley owns 296 shares worth approximately $7,833. Meanwhile, Tower Research Capital LLC reduced its holdings by 15 shares, now holding 20 shares valued at $535. UBS Group AG exited its position by selling 23 shares, leaving it with none.
Aditxt, Inc. Stock Up 104.3%
Shares of Aditxt, Inc. (NasdaqCM: ADTX) are currently trading around $0.01. The company has a market capitalization of approximately $10,607. The stock has seen a wide 52-week range, from a low of $0.01 to a high of $53,453.52. Aditxt exhibits a 50-day moving average of $4.76 and a 200-day moving average of $4,111.49.
$ADTX stock price
Daily closing prices, year to date. Not investment advice.
Insider Buying and Selling at Aditxt, Inc.
Recent insider transactions at Aditxt include HRT Financial LP's purchase of 4,252,767 shares on June 12, 2026. Additionally, on June 11, Bank of America Corp /DE/ sold 15 shares and bought 7 shares at prices of $0.01 and $0.01, respectively. Earlier, on June 10, HRT Financial LP purchased 725,330 shares at $0.02.
Analysts Set New Price Targets
On September 6, 2023, H.C. Wainwright reiterated its 'buy' rating for Aditxt, Inc., setting a price target of $61.
About Aditxt, Inc.
Aditxt, Inc. is a biotechnology company based in Mountain View, California. It focuses on the discovery and development of biopharmaceutical products, including immune monitoring technologies and treatments for autoimmune diseases. Led by CEO Jeffrey M. Busch, the company aims to provide innovative solutions in the healthcare sector.
Bottom Line
HRT Financial LP's recent purchase of Aditxt shares highlights its interest in the biotechnology firm. Investors often track such insider activities for insights, although these transactions do not necessarily predict future stock performance.
Get Aditxt, Inc. alerts
New 13F filings, insider trades, and analyst moves on $ADTX, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.